Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding

摘要

Purpose Discontinuing low-dose acetylsalicylic acid (ASA) therapy after upper gastrointestinal bleeding (UGIB) may increase the risk of cardiovascular-related death. Our aim was to compare mortality in UK primary care patients who discontinue ASA after UGIB with that in patients who continue therapy.